Showing results (61-70 of 155) with videos related to
Sort By:
Pageof 16
Hepatic Oncology|June 4, 2021
Endotrophin, a pro-peptide of Type VI collagen, is a biomarker of survival in cirrhotic patients with hepatocellular carcinomaDiana Julie Leeming, Signe Holm Nielsen, Roslyn Vongsuvanh, et al.Hepatic Oncology|April 29, 2014
A perspective on molecular therapy in cholangiocarcinoma: present status and future directionsJesper B Andersen, Snorri S ThorgeirssonHepatic Oncology|November 12, 2021
Imaging of chemotherapy-induced liver toxicity: an illustrated overviewGiovanni Brondani Torri, Matheus Dorigatti Soldatelli, Gustavo Felipe Luersen, et al.Hepatic Oncology|January 30, 2025
Comparison of long-term clinical outcomes between radiofrequency ablation and hepatic resection in patients with small (≤2 cm) hepatocellular carcinomaYoung Mi HongHepatic Oncology|September 12, 2026
Racial and ethnic survival disparities in primary liver cancer in the United States: a National Cancer Database propensity score-matched studyMuhammet Ozer, Suleyman Y Goksu, Amy L Jones, et al.Hepatic Oncology|October 27, 2023
The predictive value of liver tests for the presence of liver metastasesAlexandra V Kimchy, Harjit Singh, Esha Parikh, et al.Hepatic Oncology|November 12, 2021
Evaluation of tumor mutational burden in small early hepatocellular carcinoma and progressed hepatocellular carcinomaMary Wong, Jong T Kim, Brian Cox, et al.Hepatic Oncology|August 19, 2021
Unresectable hepatocellular carcinoma treatment with doxorubicin-eluting polyethylene glycol microspheres: a single-center experienceGerardo Tovar-Felice, Andrés García-Gámez, Virgilio Benito-Santamaría, et al.Hepatic Oncology|October 10, 2017
The status of transarterial chemoembolization treatment in the era of precision oncologyValerie Fako, Xin Wei WangPageof 16